- Home
- MKTX vs LNTH Comparison
MKTX vs LNTH Comparison
Compare MKTX & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MKTX | LNTH |
|---|---|---|
| Founded | 2000 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 6.6B |
| IPO Year | 2004 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MKTX | LNTH |
|---|---|---|
| Price | $163.55 | $100.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 6 |
| Target Price | ★ $204.88 | $87.00 |
| AVG Volume (30 Days) | 774.9K | ★ 903.8K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.94% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 4.13 | 2.91 |
| Revenue | ★ $397,471,000.00 | $343,374,000.00 |
| Revenue This Year | $10.14 | N/A |
| Revenue Next Year | $7.22 | $14.19 |
| P/E Ratio | $39.57 | ★ $34.57 |
| Revenue Growth | ★ 7.45 | 3.62 |
| 52 Week Low | $108.75 | $49.67 |
| 52 Week High | $195.97 | $111.86 |
Technical Indicators
Market Signals| Indicator | MKTX | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 79.51 | 45.37 |
| Support Level | $163.18 | $99.92 |
| Resistance Level | $163.77 | $101.43 |
| Average True Range (ATR) | 0.36 | 0.46 |
| MACD | -0.96 | 0.08 |
| Stochastic Oscillator | 94.21 | 25.88 |
Price Performance
Historical ComparisonAbout MKTX MarketAxess Holdings Inc.
Founded in 2000, MarketAxess is a leading electronic fixed-income trading platform that connects broker/dealers and institutional investors. The company is primarily focused on credit based fixed income securities with its main trading products being US investment-grade and high-yield bonds, Eurobonds, and Emerging Market corporate debt. Recently the company has expanded more aggressively into Treasuries and municipal bonds with the acquisitions of LiquidityEdge and MuniBrokers in 2019 and 2021, respectively. The company also provides pre- and post-trade services with its acquisition of Regulatory Reporting Hub from Deutsche Börse Group in 2020 adding to its product offerings.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.